Abstract
Based on the spike protein of the SARS-CoV-2 virus, a protein capable of causing an immune answer has been predicted. The protein stability in solution is confirmed by the molecular dynamics simulation. Immunomodulation has shown that this protein causes an immune reaction and, correspondingly, may serve a vaccine prototype.
REFERENCES
J. F.-W. Chan, S. Yuan, K.-H. Kok, et al., Lancet 395 (10223), 514 (2020). https://doi.org/10.1016/S0140-6736(20)30154-9
N. Zhu, D. Zhang, W. Wang, et al., N. Engl. J. Med. 382, 727 (2020). https://doi.org/10.1056/NEJMoa2001017
WHO, Coronavirus Disease (COVID-19) Dashboard (World Heal. Organ, 2020).
WHO, Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (2019-nCoV) Infection Is Suspected: Interim Guidance.
G. S. Randhawa, M. P. M. Soltysiak, H. El Roz, et al., PLoS ONE 16 (1), 0232391 (2020). https://doi.org/10.1371/journal.pone.0232391
K. Dongwan, J.-Y. Lee, J.-S. Yang, et al., Cell 181 (4), 914 (2020). https://doi.org/10.1016/j.cell.2020.04.011
WHO, Draft Landscape of COVID-19 Candidate Vaccines (WHO, Geneva, 2020).
R. F. Smith Trevor, A. Patel, S. Ramos, et al., Nat. Commun. 11, 2610 (2020). https://doi.org/10.1038/s41467-020-16505-0
J. Mulligan Mark, K. E. Lyke, N. Kitchin, et al., Nature 586, 589 (2020). https://doi.org/10.1038/s41586-020-2639-4
F.-C. Zhu, X.-H. Guan, Y.-H. Li, et al., Lancet 396 (10249), 479 (2020). https://doi.org/10.1016/S0140-6736(20)31605-6
Q. Gao, L. Bao, H. Mao, et al., Science 369 (6499), 77 (2020).
Y. Cao, A. Yisimayi, F. Jian, et al., Nature 608, 593 (2022). https://doi.org/10.1038/s41586-022-04980-y
T. M. Gallagher and M. J. Buchmeier, Virology 279 (2), 371 (2001). https://doi.org/10.1006/viro.2000.0757
https://pymol.org/2/
M. J. Abraham, T. Murtola, R. Schulz, et al., SoftwareX 1, 19 (2015). https://doi.org/10.1016/j.softx.2015.06.001
K. Lindorff-Larsen, S. Piana, K. Palmo, et al., Proteins 78, 1950 (2010). https://doi.org/10.1002/prot.22711
H. J. C. Berendsen, J. P. M. Postma, W. F. van Gunsterenvan, et al., J. Chem. Phys. 81 (8), 3684 (1984). https://doi.org/10.1063/1.448118
M. Parrinello and A. Rahman, J. Chem. Phys. 76 (5), 2662 (1982). https://doi.org/10.1063/1.443248
B. Hess, H. Bekker, J. C. Herman, et al., J. Comput. Chem. 18, 1463 (1997). https://doi.org/10.1002/(SICI)1096
T. Darden, D. York, and L. Pedersen, J. Chem. Phys. 98 (12), 10089 (1993). https://doi.org/10.1063/1.464397
https://kraken.iac.rm.cnr.it/C-IMMSIM/index.php
R. V. Luckheeram, R. Zhou, A. D. Verma, and B. Xia, J. Immunol. Res. 925135 (2012). https://doi.org/10.1155/2012/925135
N. Rapin, O. Lund, M. Bernaschi, and F. Castiglione, PubMed (2010). https://doi.org/10.1371/journal.pone.000986
Funding
This work was supported by the Ministry of Science and Higher Education of the Russian Federation within the Federal Science and Technology Program for the Development of Synchrotron and Neutron Studies and Research Infrastructure for 2019–2027 (agreement no. 075-15-2021-1355 on October 12, 2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors of this work declare that they have no conflicts of interest.
Additional information
Translated by Yu. Sin’kov
Publisher’s Note.
Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ivanovsky, A.S., Kolesnikov, I.A., Kordonskaya, Y.V. et al. Application of the Crystal Structure of the SARS-CoV-2 Spike Protein for the Development of a Peptide Vaccine against Virus. Crystallogr. Rep. 68, 951–954 (2023). https://doi.org/10.1134/S1063774523601065
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1063774523601065